Experimental drug to treat liver cancer shows evidence of activity with manageable side effects

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainA new drug that inhibits an enzyme playing a crucial role in cell division and growth has shown signs of a

Updated on: February 20,2024

Experimental drug to treat liver cancer shows evidence of activity with manageable side effects

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainA new drug that inhibits an enzyme playing a crucial role in cell division and growth has shown signs of a

Updated on:February 20,2024

A myeloma-targeting monoclonal antibody offers new hope for treating multiple myeloma

by Osaka UniversitySummary of the research. Credit: Naoki HosenMultiple myeloma (MM) is a largely incurable cancer of plasma cells with an extremely poor prognosis. However, investigators from Ja

Updated on: May 07,2024

A myeloma-targeting monoclonal antibody offers new hope for treating multiple myeloma

by Osaka UniversitySummary of the research. Credit: Naoki HosenMultiple myeloma (MM) is a largely incurable cancer of plasma cells with an extremely poor prognosis. However, investigators from Ja

Updated on:May 07,2024

Blood tests could offer smarter treatment for children's cancer

byInstitute of Cancer ResearchRhabdomyosarcoma cells. Credit: Dr Ewa Aladowicz, ICRA simple blood test could help guide the treatment of children with the cancer rhabdomyosarcoma, a new study re

Updated on: January 15,2024

Blood tests could offer smarter treatment for children's cancer

byInstitute of Cancer ResearchRhabdomyosarcoma cells. Credit: Dr Ewa Aladowicz, ICRA simple blood test could help guide the treatment of children with the cancer rhabdomyosarcoma, a new study re

Updated on:January 15,2024

Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

by Cancer Research UKCredit: CC0 Public DomainA drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treat

Updated on: May 11,2024

Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

by Cancer Research UKCredit: CC0 Public DomainA drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treat

Updated on:May 11,2024

Subtypes of fibroblasts associated with skin cancer could lead to novel immunotherapies

byMedical University of ViennaSchematic summary of spatial distribution of distinct CAF subsets in human skin cancer. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-5390

Updated on: December 01,2024

Subtypes of fibroblasts associated with skin cancer could lead to novel immunotherapies

byMedical University of ViennaSchematic summary of spatial distribution of distinct CAF subsets in human skin cancer. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-5390

Updated on:December 01,2024

New research could prevent jaw damage in patients being treated for cancer or osteoporosis

by Gary Polakovic,University of Southern CaliforniaOsteonecrosis of the jaw is a rare, incurable side effect of some drug treatments. Credit: Photo/Science SourceUSC researchers and collaborator

Updated on: May 21,2024

New research could prevent jaw damage in patients being treated for cancer or osteoporosis

by Gary Polakovic,University of Southern CaliforniaOsteonecrosis of the jaw is a rare, incurable side effect of some drug treatments. Credit: Photo/Science SourceUSC researchers and collaborator

Updated on:May 21,2024

Role of cancer protein ARID1A at intersection of genome stability and tumor suppression

by The Wistar InstituteRugang Zhang, Ph.D., The Wistar Institute. Credit: The Wistar InstituteThe ARID1A tumor suppressor protein is required to maintain telomere cohesion and correct chromosome

Updated on: April 09,2024

Role of cancer protein ARID1A at intersection of genome stability and tumor suppression

by The Wistar InstituteRugang Zhang, Ph.D., The Wistar Institute. Credit: The Wistar InstituteThe ARID1A tumor suppressor protein is required to maintain telomere cohesion and correct chromosome

Updated on:April 09,2024

A comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries

by National Institutes of HealthTumor types and data types of the CPTAC pan-cancer dataset. Overview of the available molecular data types for the CPTAC pan-cancer cohort (n= 1072, see Tabl

Updated on: February 20,2024

A comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries

by National Institutes of HealthTumor types and data types of the CPTAC pan-cancer dataset. Overview of the available molecular data types for the CPTAC pan-cancer cohort (n= 1072, see Tabl

Updated on:February 20,2024

COVID-19 booster vaccine doses strengthen immunity in blood cancer patients, shows study

by University of SouthamptonCredit: Pixabay/CC0 Public DomainResearch by the University of Southampton into the effectiveness of COVID-19 vaccines in people with lymphoma has shown that repeated

Updated on: February 20,2024

COVID-19 booster vaccine doses strengthen immunity in blood cancer patients, shows study

by University of SouthamptonCredit: Pixabay/CC0 Public DomainResearch by the University of Southampton into the effectiveness of COVID-19 vaccines in people with lymphoma has shown that repeated

Updated on:February 20,2024

Adding tucatinib to drug combination extends survival for advanced HER2+ breast cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center today reported study results showing the addition of

Updated on: April 23,2024

Adding tucatinib to drug combination extends survival for advanced HER2+ breast cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center today reported study results showing the addition of

Updated on:April 23,2024

Adding vaccine to immunotherapy for liver cancer shows promise in early trial

by Dennis ThompsonClinical response. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-02894-yA custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to sh

Updated on: April 28,2024

Adding vaccine to immunotherapy for liver cancer shows promise in early trial

by Dennis ThompsonClinical response. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-02894-yA custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to sh

Updated on:April 28,2024

Experimental test promises to predict side-effects and cancer's return in patients treated with immunotherapy

by NYU Langone HealthCancer cell during cell division. Credit: National Institutes of HealthA single research test has the potential to predict which patients treated with immunotherapies—which h

Updated on: February 23,2024

Experimental test promises to predict side-effects and cancer's return in patients treated with immunotherapy

by NYU Langone HealthCancer cell during cell division. Credit: National Institutes of HealthA single research test has the potential to predict which patients treated with immunotherapies—which h

Updated on:February 23,2024